Current Value
$28.511 Year Return
Current Value
$28.511 Year Return
Double maintains 2 strategies that include KNSA - Kiniksa Pharmaceuticals International Plc
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LTC | 0.07% | $1.59B | +0.03% | 6.60% |
NBIS | -0.17% | $12.34B | +173.71% | 0.00% |
MVO | 0.19% | $66.13M | -38.96% | 21.90% |
CARM | 0.22% | $16.74M | -73.64% | 0.00% |
TEF | -0.23% | $29.29B | +23.28% | 6.30% |
CVLT | -0.23% | $7.69B | +43.40% | 0.00% |
CQP | 0.24% | $26.95B | +13.38% | 5.87% |
KOF | -0.24% | $4.96B | +9.96% | 4.38% |
AMR | 0.27% | $1.37B | -62.61% | 0.00% |
DG | -0.27% | $25.19B | -13.45% | 2.07% |
BTCT | 0.33% | $18.98M | +37.85% | 0.00% |
OXBR | 0.33% | $13.03M | -26.47% | 0.00% |
PPC | 0.41% | $10.57B | +30.66% | 0.00% |
CPSH | -0.41% | $40.67M | +64.71% | 0.00% |
TTEK | 0.42% | $9.39B | -12.85% | 1.32% |
EQNR | -0.42% | $68.66B | -8.28% | 5.67% |
TTE | -0.47% | $137.25B | -7.77% | 5.73% |
HTZ | 0.48% | $1.00B | +100.28% | 0.00% |
NFE | -0.51% | $685.45M | -88.63% | 0.00% |
NEXA | 0.55% | $654.25M | -35.34% | 0.00% |
Yahoo
Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.
SeekingAlpha
Baker Brothersâ Q1 2025 portfolio reveals biotech investment trends. See more on their top holdings, stake changes, and high-conviction strategies.
SeekingAlpha
Kiniksa Pharmaceuticals sees strong growth from Arcalyst, aided by Medicare redesign. Learn about 2025 sales outlook & upcoming drug developments.
Finnhub
Presenter SpeechKyuwon Choi Thank you. Good morning, everyone. I'm Paul Choi. I'm a biotech analyst here at Goldman Sachs. It's my pleasure to welcome Kiniksa for our first session this morning on
Finnhub
Jefferies Global Healthcare Conference JUNE 5 , 2025 ...
Yahoo
– KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 –– KPL-387 Phase 1 single ascending dose data support profile for monthly dosing –– Presentation and webcast at Jefferies 2025 Global Healthcare Conference scheduled for 12:50 pm ET today– LONDON, June 05, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, wi
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 40.25% | $4.95B | 0.35% |
IWC | 37.94% | $824.65M | 0.6% |
GNOM | 36.59% | $44.43M | 0.5% |
PINK | 36.44% | $133.06M | 0.5% |
IWM | 35.51% | $64.00B | 0.19% |
VTWO | 35.51% | $13.29B | 0.07% |
PBE | 35.38% | $223.24M | 0.58% |
PSC | 35.06% | $747.92M | 0.38% |
FYX | 35.03% | $819.32M | 0.6% |
IWN | 34.96% | $10.89B | 0.24% |
PTH | 34.76% | $101.07M | 0.6% |
XPH | 34.70% | $149.79M | 0.35% |
GSSC | 34.68% | $586.95M | 0.2% |
IWO | 34.55% | $11.48B | 0.24% |
IBB | 34.23% | $5.36B | 0.45% |
PRFZ | 34.17% | $2.36B | 0.34% |
BSVO | 33.89% | $1.46B | 0.47% |
XSVM | 33.86% | $571.12M | 0.37% |
KJUL | 33.80% | $120.75M | 0.79% |
XSMO | 33.65% | $1.67B | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPTS | -0.06% | $5.78B | 0.03% |
TBLL | 0.12% | $2.13B | 0.08% |
DBO | -0.12% | $226.76M | 0.77% |
IBND | 0.12% | $378.69M | 0.5% |
FTGC | 0.13% | $2.39B | 0.98% |
GSG | 0.34% | $961.35M | 0.75% |
BSMW | 0.36% | $107.26M | 0.18% |
OILK | 0.42% | $71.89M | 0.69% |
DBE | -0.46% | $52.44M | 0.77% |
SUB | 0.50% | $9.91B | 0.07% |
SHM | -0.51% | $3.41B | 0.2% |
PDBC | -0.55% | $4.39B | 0.59% |
SOYB | 0.55% | $25.31M | 0.22% |
DBC | -0.56% | $1.22B | 0.87% |
BCI | 0.64% | $1.58B | 0.26% |
CERY | 0.75% | $460.65M | 0.28% |
COMT | -0.86% | $605.97M | 0.48% |
BNO | -0.89% | $103.68M | 1% |
USL | 1.01% | $42.26M | 0.85% |
FXC | 1.03% | $92.55M | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -26.58% | $165.69M | 0.85% |
TAIL | -22.51% | $99.76M | 0.59% |
BTAL | -19.94% | $296.79M | 1.43% |
WEAT | -16.60% | $117.15M | 0.28% |
CLIP | -13.62% | $1.52B | 0.07% |
CORN | -11.87% | $44.21M | 0.2% |
CTA | -10.27% | $1.06B | 0.76% |
XHLF | -8.84% | $1.73B | 0.03% |
TFLO | -8.67% | $6.83B | 0.15% |
IVOL | -7.85% | $349.27M | 1.02% |
FXY | -6.78% | $815.67M | 0.4% |
FXE | -6.43% | $568.58M | 0.4% |
BILS | -6.02% | $3.86B | 0.1356% |
CNYA | -5.53% | $205.89M | 0.6% |
FTSM | -5.02% | $6.40B | 0.45% |
BIL | -4.91% | $42.87B | 0.1356% |
ASHR | -4.78% | $1.91B | 0.65% |
KBA | -4.34% | $175.97M | 0.56% |
UDN | -4.19% | $147.88M | 0.78% |
XBIL | -4.03% | $783.57M | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KREF | 44.01% | $612.79M | -0.44% | 11.24% |
EFSC | 40.18% | $2.06B | +36.23% | 2.04% |
CCK | 39.90% | $12.05B | +39.13% | 0.99% |
NWBI | 39.65% | $1.64B | +11.08% | 6.23% |
TRS | 39.26% | $1.15B | +11.03% | 0.56% |
NBTB | 38.83% | $2.19B | +8.52% | 3.25% |
CECO | 38.30% | $1.04B | +2.60% | 0.00% |
ATI | 37.62% | $12.24B | +56.54% | 0.00% |
MSCI | 37.24% | $44.60B | +19.65% | 1.18% |
BEAM | 36.58% | $1.69B | -28.30% | 0.00% |
WASH | 35.80% | $544.97M | +3.06% | 7.89% |
OCFC | 35.71% | $1.03B | +11.52% | 4.49% |
ZION | 35.56% | $7.60B | +18.68% | 3.27% |
SEVN | 35.43% | $179.32M | -5.13% | 11.62% |
NECB | 35.24% | $327.31M | +31.79% | 2.56% |
TCBK | 35.13% | $1.35B | +4.07% | 3.20% |
WAFD | 35.04% | $2.35B | +2.59% | 3.62% |
SAP | 35.04% | $351.25B | +49.27% | 0.87% |
SHW | 34.70% | $86.64B | +15.85% | 0.87% |
CPRX | 34.56% | $2.66B | +40.61% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -13.44% | $21.70M | -78.27% | 0.00% |
KMB | -13.18% | $42.44B | -7.46% | 3.88% |
K | -10.40% | $27.41B | +36.96% | 2.88% |
TV | -8.43% | $1.01B | -17.69% | 0.00% |
CBOE | -8.26% | $23.98B | +34.66% | 1.10% |
NSP | -7.64% | $2.23B | -35.03% | 4.02% |
PSQH | -7.44% | $93.81M | -45.36% | 0.00% |
WM | -5.60% | $91.85B | +6.99% | 1.38% |
PCAR | -4.12% | $49.81B | -5.17% | 1.32% |
STG | -3.96% | $29.06M | -28.79% | 0.00% |
PRPO | -3.34% | $16.43M | +109.40% | 0.00% |
CME | -3.32% | $99.01B | +39.76% | 3.87% |
ZCMD | -3.20% | $28.79M | -13.64% | 0.00% |
PHYS | -3.18% | - | - | 0.00% |
HUSA | -3.11% | $22.94M | -6.82% | 0.00% |
RLX | -2.96% | $2.02B | +20.65% | 0.45% |
SRRK | -2.86% | $3.40B | +329.89% | 0.00% |
ALHC | -2.52% | $2.74B | +77.11% | 0.00% |
ZTO | -2.47% | $10.56B | -14.31% | 3.99% |
ASPS | -2.31% | $95.51M | -23.85% | 0.00% |